Angiogenic response of MCF7 human breast cancer to hormonal treatment: Assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution

Journal of Magnetic Resonance Imaging

Volumn 6, Issue 1, 1996, Pages 195-202

  Furman Haran, Edna ^a   Margalit, Raanan ^a   Maretzek, António F ^a   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Angiogenesis; Breast cancer; Endothelial cells; Estrogen; MRI; Tamoxifen

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ESTRADIOL; GADOLINIUM PENTETATE; ORGANOMETALLIC COMPOUND; PENTETIC ACID; TAMOXIFEN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; METHODOLOGY; MOUSE; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PATHOLOGY; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CONTRAST MEDIA; ESTRADIOL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NECROSIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; TAMOXIFEN;

EID: 0029680145     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880060135     Document Type: Article

References (25)

1. DeSombre ER, Hughes A, King WJ, Galley SJ. Schwartz JL, Harper FV. Steroid receptors and breast cancer: current status and new applications for receptor-directed diagnosis and therapy, in breast cancer: progress in biology, clinical management and prevention. In: Rich MA, Hager JC, Keydar L, eds. Boston: Kluwer Academic Press, 1989; 155-169.
2. Shafie SM, Grantham FH. Role of hormones in the growth and regression of human breast cancer cells (MCF7) transplanted in athymic nude mice. J Natl Cancer Inst 1981; 67:51-56.
3. Haran-Furman E, Maretzek AF, Goldberg I, Horowitz A, Degani H. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 1994; 54: 5511-5514.
4. Osborne CK, Hobbs K, Clark GM. Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 1985; 45:584-590.
5. Osborne CK, Coronado EB, Robinson JP. Human breast cancer in athymic nude mouse: cytostatic effects of long term antiestrogen therapy. Eur J Cancer Clin Oncol 1987; 23:1189-1196.
6. Brunner N, Bronzert D, Vindelov LL, Rygaard K, Spang-Thomsen M, Lippman ME. Effect of growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 1989; 49:1515-1520.
7. Furman E, Margalit R, Bendel P, Horowitz A, Degani H. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun 1991; 3(9):287-297.
8. Furman E, Rushkin E, Margalit R, Bendel P, Degani H. Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging. J Steroid Biochem Mol Biol 1992; 43:189-195.
9. Heywang-Kobrunner SH. Contrast-enhanced MRI of the breast. Berlin: HD Med. Information, Sektion Medizinische Redaktion, Schering, 1990.
10. Harms SE, Flaming DP. MR imaging of the breast. J Magn Reson Imaging 1993; 3:277-283.
11. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17: 357-367.
12. Belfi CA, Ting LL. Hassenbusch SJ, Tefft M, Ngo FQH. Determination of changes in tumor blood perfusion after hydralazine treatment by dynamic paramagnetic-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1992; 22:477-482.
13. Gamarra F, Naegele M, Lumper W, Goetz AE. Acute effects of shock waves on tumors assessed by magnetic resonance imaging. Possible role of blood flow reduction. Invest Radiol 1993; 28 (7):611-618.
14. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992; 27 (10):847-855.
15. Hanna SL, Parham DM, Fairclough DL, Meyer WH. Le AH, Fletcher BD. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol 1992; 27(5):367-373.
16. Hanna SL, Reddick WE, Parham DM, Gronemeyer SA, Taylor JS, Fletcher BD. Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results. J Magn Reson Imaging 1993; 3:849-853.
17. Kennedy SD, Szczepaniak LS, Gibson SL, Hilf R, Foster TH, Bryant RG. Quantitative MRI of Gd-DTPA uptake in tumors: response to photodynamic therapy. Magn Reson Med 1994; 31: 292-301.
18. Alroy J. Goyal V, Skutelsky E. Lectin histochemistry of mammalian endothelium. Histochemistry 1987; 86:603-607.
19. Gowland P, Mansfield P, Bullock P, Stehling M, Worthington B, Firth J. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 1992; 26:241-258.
20. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantification of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990; 16:117-131.
21. Tofts PS, Berkowitz BA. Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J Magn Reson B 1993; 102:129-136.
22. Su MY, Jao JC, Nalcioglu O. Measurement of vascular volume fraction and blood tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994; 32:714-724.
23. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641-2658.
24. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845.
25. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53:4727-4735.